North Kingstown, Rhode Island Jul 31, 2025 (Issuewire.com) - Equity Risk Sciences (ERS), the nation's only independent stock risk rating agency, today announced a $20 million capital raise at $10.00 per share to fuel a national communications campaign highlighting investors #1 need: to reduce, prevent and avoid losses.

12 years ago today, Raymond Mullaney, founder of ERS, hired Tom Harpin, an exceptional mathematician and data scientist. Mullaneys goal: Transform investing by utilizing the most advanced technology, data science and AI, making it safer, smarter, and more rewarding. See Investor Handout at www.ERS.ai, outlining 15 compelling reasons to join ERSs revolutionary investment opportunity.

"We've engineered proprietary risk ratings which, when used, will substantially reduce investor losses," declared Mullaney.

Disrupting a $100 Trillion Industry with Proven Science

ERS addresses the most critical question investors rarely ask: Whats the risk? The companys proprietary ratings consistently identify companies destined for catastrophic losses while highlighting those positioned for sustainable returnsvalidated by a decade of rigorous testing across all market periods in the past 25 years.

This capital raise will accelerate three strategic initiatives:

• National Investment Risk Awareness Campaign: A comprehensive education initiative led by respected leaders across the political spectrum, rallying investors around the core principle: "Know the Risks Before You Invest."
• Premium Institutional Products: Launch of the exclusive Fiduciary Approved Stock Lista high-margin subscription service available to select institutions. Those approved will earn the exclusive right to advertise their use of ERSs trusted lista premium branding advantage, and a powerful new revenue stream for subscribers and ERS.
• Launch of InvestLabs.ai Platform: Funding will also support the development and rollout of InvestLabs.ai, ERSs institutional-grade platform for risk analytics, portfolio design and testing, and advanced investment research. InvestLabs.ai will provide subscribers with access to ERSs powerful suite of toolsincluding the Profit Map, Portfolio Risk Analyzer, Present Screener, Multi Portfolio Screener, Active Risk Monitoring, Decision Metrics and Stock Prognosis, to name a fewand the ability to design, build, test, and refine their own proprietary portfolio strategies.

The platforms built-in research lab will allow analysts to test the predictive power of over 100 different financial metrics, helping them identify which metrics reliably improve performance and reduce risk. Whether building model portfolios, back-testing strategies, or designing proprietary ratings, InvestLabs.ai gives investment professionals a profound edgecombining ERSs proven data science with flexible, advisor-driven innovation.

 More On Newspulsebyte ::

•   Cristina Plinio, Recognized by BestAgents.us as a 2024 Top Agent
•   Jesse Wolfe, DPM, FACFAS, Elevates Podiatric Specialty Surgery in Rural Midwest
•   Dedication in Action: Marilyn Hodges, RRT-NPS, at St. Jude Children’s Research Hospital
•   Larry Rebich, RN, MPH, BSN, CNOR: A Beacon of Excellence in Nursing at Greenwich Hospital
•   A Story of Survivial: Emre Bardan's Triump Over Addiction and Exploitation

Powered by Purpose, Proven by Data, Driven by Results

ERS's technology has undergone exhaustive testing against decades of market data, consistently demonstrating superior accuracy in identifying both high-risk investments and stable, profitable opportunities. This proven track record positions ERS to capture significant market share in the growing risk management sector.

The company's business model generates revenue through multiple streams: institutional subscriptions, fiduciary tools licensing, and premium advisory servicescreating a sustainable, scalable platform for long-term growth.

ERS has rigorously honed its technology using 35+ years of data from 15,000+ public companies. The verdict? Our risk ratings pinpoint catastrophe-prone stocks with precisionand spotlight those primed for robust, enduring gains.

About ERS

Equity Risk Sciences is America's only fully independent stock risk rating agency, using advanced technology and AI to create ratings that reliably forecast the probability, scale, and timing of stock price movements. ERSs ratings help fiduciaries and financial institutions avoid, prevent and reduce losses and capture gains on stocks suitable for fiduciaries, making investing safer and more rewarding.

ERS doesn't sell stocks. We built Risk Ratings to Protect Capital.

Contact Francesca Okleasky, communications manager, at (203) 254-0000 or [email protected] to arrange a call or meeting with Mr. Mullaney.

For the complete Investor Handout detailing 15 compelling reasons to invest in ERS, visit: www.ERS.ai